Cleara Biotech
PrivateLast Round
Seed
Sep 28, 2022
Total Funding Raised
$2.5M
Company Overview
Cleara Biotech is a biotechnology company that develops peptide-based therapies to eliminate senescent cells for the treatment of cancer and chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cleara Biotech Comparables
Compare Cleara Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Numeric Biotech | 87% | |
| Deciduous Therapeutics | 87% | |
| StarkAge Therapeutics | 86% |
Cleara Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 28, 2022 | ||||
| Seed | Jul 6, 2018 |
Cleara Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ROM Utrecht Region | Seed |
| Longevitytech.fund | Seed |
| Infinitas Capital | Convertible Debt |
| Korify Capital | Convertible Debt |
| Curie Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 228% MoM.
- Apr 20, 2026
Monthly visitors increased 613% MoM.
Cleara Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cleara Biotech's valuation, stock price, and market status.
Is Cleara Biotech a public or private company?
Cleara Biotech is a private company.
What is the current stock price of Cleara Biotech?
Cleara Biotech is a private company, so its shares have no public market price. Caplight tracks Cleara Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cleara Biotech worth (valuation)?
Valuation information for Cleara Biotech is not publicly available.
Can I buy Cleara Biotech stock?
Cleara Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cleara Biotech's last funding round?
Cleara Biotech's most recent funding round was Seed on September 28, 2022.
Who are the main investors in Cleara Biotech?
Key investors in Cleara Biotech include ROM Utrecht Region, Longevitytech.fund, Infinitas Capital, Korify Capital, Curie Capital.
Will Cleara Biotech IPO soon?
No public IPO plans have been announced for Cleara Biotech.
How can I track Cleara Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Cleara Biotech's shares on secondary markets.